Voyage is hiring Clinical Staff - contact us to find out more!

Healing from Within: Ketamine Therapy and its Neuroplastic Effects

Healing from Within: Ketamine Therapy and its Neuroplastic Effects

Professional ketamine therapy has recently been gaining increased popularity as a treatment for a myriad of mental health issues including: depression, anxiety, addiction, PTSD, and chronic pain. While you might have heard about ketamine treatment or ketamine infusion therapy, many people are still confused about why ketamine works as an effective therapeutic treatment. This blog post will explore three different research studies that explain ketamine’s ability to affect the neuroplasticity of the brain. 

What is Neuroplasticity? 

Neuroplasticity, sometimes referred to as neural plasticity or brain plasticity, refers to the brain’s remarkable capacity to undergo growth and reorganization. This function enables the brain to adapt and change over time. These adaptations can manifest as changes to the brain following injury or as structural changes facilitated by learning experiences. Examples of neuroplasticity include learning a new language, mastering musical skills, or memorizing navigation routes within your city.

Rapid Neuroplasticity Changes and Response to Intravenous Ketamine

This study was conducted by various university medical departments including Carnegie Mellon University, University of Pittsburgh School of Medicine, and Baylor College of Medicine and Michael E. DeBakey VA Medical Center examined how ketamine affects the brain’s ability to change and adapt, known as neuroplasticity, which is thought to help treat depression rapidly. Researchers studied 98 adults with depression who hadn’t improved with other medications. They found that after receiving a single dose of ketamine, the brain showed signs of increased neuroplasticity within 24 hours, and those who had the most changes in certain brain regions had the biggest improvements in their depression symptoms. This suggests that ketamine’s fast-acting effects on depression may be linked to its ability to enhance neuroplasticity in the brain.


Ketamine Enhances Structural Plasticity in Mouse Mesencephalic and Human iPSC-derived Dopaminergic Neurons via AMPAR-driven BDNF and mTOR Signaling

This global study is affiliated with the Department of Molecular and Translational Medicine in University of Brescia, Italy, Department of Biomedicine in the University of Basel, Switzerland, and the CNS Therapeutic Area Unit in Takeda Development Center Europe. Here they explored how ketamine affects the brain’s ability to change its structure, a process called neuroplasticity, which is important for treating depression. They found that ketamine triggers a series of molecular events that lead to structural changes in specific neurons related to mood regulation. These changes were similar in both mouse and human neurons, suggesting that ketamine might work the same way in different species. Understanding how ketamine affects brain cells could help improve treatments for depression and other mood disorders.

The Mechanisms Behind Rapid Antidepressant Effects of Ketamine: A Systematic Review With a Focus on Molecular Neuroplasticity

This study was conducted in Ontario, Canada by the Center of Neuroscience Studies (CNS) in Queen’s University, the Department of Psychiatry in Queen’s University School of Medicine, and the Providence Care Hospital in Kingston. The study delved into how ketamine might swiftly alleviate depression by enhancing neuroplasticity in the brain, a crucial process for adapting to changes. The researchers examined 139 scientific papers detailing experiments conducted in cell cultures, animal models, and patients with depression. They found that ketamine increases specific molecules involved in neuroplasticity, such as glutamate, AMPA receptors, mTOR, BDNF/TrkB, and others. These molecular changes were observed to coincide with rapid improvements in mood. This suggests that ketamine’s ability to boost neuroplasticity may contribute to its effectiveness in treating depression quickly.


With these studies and their key findings, it is easier to understand ketamine’s effect on the brain and its ability to improve neuroplasticity. By revealing the molecular processes involved, researchers have uncovered important insights into how ketamine quickly alleviates depression. This knowledge not only deepens our grasp of treating depression but also paves the way for new therapies targeting neuroplasticity. As research progresses, ketamine holds promise for transforming mental health care, offering hope to those with treatment-resistant depression and related conditions.

Request An Appointment

"*" indicates required fields

Preferred contact method?*